Case File
efta-efta00585323DOJ Data Set 9OtherSUMMARY OF PROPOSED TERMS
Date
Unknown
Source
DOJ Data Set 9
Reference
efta-efta00585323
Pages
6
Persons
0
Integrity
No Hash Available
Extracted Text (OCR)
Text extracted via OCR from the original document. May contain errors from the scanning process.
SUMMARY OF PROPOSED TERMS
SERIES A PREFERRED SHARES
Reporty Homeland Security Ltd.
December
, 2014
We are happy to confirm our interest, subject to all terms and conditions herein, to explore the
possibility of an investment in Reporty Homeland Security Ltd. This letter summarizes the
principal terms of a proposed investment for Preferred A Shares. Except as specifically provided
herein, this letter is not intended to be a legally binding agreement but is a statement of intent. It
is presented solely for the purpose of discussion.
Company
Reporty Homeland Security Ltd., an Israeli company (the "Company").
Founders
Amir Elichai, Alexander Dizengoff, Yoni Yitzon & Lital Leshem
Investor
An entity under the control of Mr. Ehud Barak (the "Investor").
Structure of Financing
Investor shall invest in the Company up to an aggregate amount of US$
1,500,000 (the "Investment Amount"), against issuance by the Company of
Preferred Shares at the Closing (as such terms are defined below) for the
entire Investment Amount at a price per share of [
1 ("PPS")
(representing a pre-money valuation of US$ [3,338,710], on a Fully Diluted
Basis (as defined below)) so that immediately following the Closing,
Investor will hold not less than [31.0%] of the Company's share capital, on a
Fully Diluted Basis.
The Investment Amount shall be provided to Company in two subsequent
equal installments as follows:
(i) an amount of US$ 750,000 out of the Investment Amount will be provided
at the Closing; and
(ii) Subject to the following, the remaining amount of US$ 750,000 out of the
Investment Amount will be provided within _ months as of the Closing,
conditioned upon achievement by the Company of the milestone(s) set forth
under Annex I of this letter at or prior to such time, to Investor's satisfactions.
Fully Diluted Basis
In this letter, "Fully Diluted Basis" includes, without limitation, all issued and
outstanding share capital of the Company, all securities issuable upon the
conversion of any existing convertible securities, notes or loans, the exercise of
all outstanding warrants, options, adjustments of numbers of shares triggered
by this financing (if any), any shares or options to acquire shares issued to any
person as a finder's fee or similar arrangement in connection with the
Investment and an unallocated option pool for future allotment to employees,
consultants and directors of the Company, representing 12% of the issued and
outstanding share capital of the Company immediately following the Closing
("Option Pool") (assuming the Warrants) (as defined below) were not
exercised by the Investor).
EFTA00585323
Capitalization Table
The detailed pre-Closing and post-Closing capitalization of the Company is
set forth in the Capitalization Table attached hereto as Exhibit A.
Conditions to Close
Closing of the transaction contemplated hereunder is subject to (i) satisfaction
of the parties due diligence requirements, including financial and legal
diligence, and (ii) the signing of mutually acceptable Definitive Agreements
(as defined below).
Estimated Closing
Date
[Closing Date] (the "Closing").
Type of Security
Series A Convertible Preferred Shares (the "Preferred Shares"), initially
convertible on a one to one basis into Ordinary Shares of the Company (the
"Ordinary Shares").
Warrants)
At the Closing, the Company will issue: (i) a first warrant to the Investor that
will allow it (or any of its assignees) to purchase additional Preferred Shares by
investing an additional amount of up to US$ 1,000,000, at an exercise price of
150% of the PPS (subject to routine recapitalization adjustment). and, in
addition (ii) a second warrant to the Investor that will allow it (or any of its
assignees) to purchase additional Preferred Shares by investing an additional
amount of up to US$ 2.500.000. at an exercise price of 175% of the PPS
(subject to routine recapitalization adjustment). conditioned upon the
exercising of the aforesaid first warrant (collectively the "Warranksy). The
Warrant(th will be valid for a period of 48 months after the Closing. Exercise
of such Warrant( %) may be cashless at the discretion of the Warrants) holder.
Use of Proceeds
The Investment Amount shall be used by the Company to continue the
development of the Company's technology, know-how, sales and marketing
programs and provide general working capital, pursuant to a budget prepared
by the Company, agreed by the Investor and attached to the Definitive
Agreements.
Liquidation / Dividend
Preference
In the event of any liquidation event, Deemed Liquidation (as defined below)
and/or distribution of dividends, the holders of the Preferred Shares will be
entitled to receive prior and in preference to any distribution of any of the
Company's assets or funds to all other equity securities of the Company (in
cash, cash equivalents, or, if applicable, securities), for each Preferred Share,
an amount equal to: (i) 100% of the PPS, plus (ii) 8% annual interest on that
amount, compounded from the Closing (together, "Preference A Amount").
Any surplus of assets or funds remaining (if any) after the payment in full of
the Preference A Amount less any amounts paid as preferential dividends prior
to that date will then be distributed pro rata among all the shareholders of the
Company, including the holders of Preferred Shares, on an as-converted basis.
A "Deemed Liquidation" shall mean any of the following transactions: an
acquisition of the Company or a merger between the Company and another
non-affiliated entity in which the shareholders of the Company do not own a
majority of the shares of the surviving entity, the sale of all or substantially all
of the Company's assets, or of the shares of the Company, an exclusive,
irrevocable license of all or substantially all of the Company's intellectual
property to a third party, or any other transaction in which control of the
Company (at least 50%) is transferred (other than a IPO or other bona fide
financing transaction).
EFTA00585324
Conversion
Each holder of Preferred Shares shall have the right to convert its shares at
any time into Ordinary Shares at an initial conversion rate of 1:1, subject to
proportional adjustment for share splits, dividends or recapitalizations or a
similar event and any anti-dilution adjustments. The Preferred Shares shall
automatically convert into Ordinary Shares if (a) the Investor consent to
such conversion or (b) upon the closing of a firmly underwritten public
offering of shares of the Company ("IPO") netting at least $30 million at a
pre-money valuation of the Company of at least $100 million (a "QIPO").
Anti-Dilution
Provisions
Until a QIPO, if the Company issues new securities at a price per share
lower than the then applicable conversion price of the Preferred Shares
(initially, the conversion price shall be the Price Per Share), then in each
such event the conversion price of the Preferred Shares shall be adjusted on
a "full ratchet" anti-dilution adjustment.
Protective Provisions
Certain important actions of the Company shall require the consent of the
Investor or the Preferred Directors (as defined below), to include amongst
others, actions to: (i) alter the rights, preferences or privileges of the
Preferred Shares; (ii) allot any new shares beyond those anticipated by this
investment; (iii) create any new class or series of shares having rights,
preferences or privileges equal or senior to the Preferred Shares; (iv)
increase the number of shares reserved for issuance to employees and
consultants, whether under the Option Pool or otherwise; (v) grant of
options to employees and consultants, whether under the Option Pool or
otherwise, on vesting terms different than the vesting terms that shall be
defined in the Definitive Agreement (as defined below); (vi) redeem or sale
of any shares; (vii) declaring or paying any dividend or other distribution of
cash, shares or other assets, other than a bonus shares issuance paid to all of
the shareholders of the Company on a pro rata basis; (viii) change the
number of Board members or otherwise changing its composition; (ix) take
any action which results in a Deem Liquidation event or otherwise
dissolving, liquidating or winding up the Company; (x) amend the
incorporations documents including Articles of Association; (xi) effect any
material change to the nature of the business; (xii) subscribe or otherwise
acquire, or dispose of any shares in the capital of any other company; (xiii)
affect any interested party transactions; (xiv) amend the signatory rights
determined under this transaction; (xv) approve the Company's annual
operating plan and budget and any material deviations from it; (xvi) entering
into a transaction with any related party; or (xvii) the appointment of the
CEO, CFO or CTO.
Voting Rights
The holders of the Preferred Shares shall vote together with the holders of
all other shares of the Company, and not as a separate class, in all
shareholders meetings, except as to matters that by law or pursuant to this
letter are subject to a class vote. Each Preferred Share shall entitle the holder
thereof to such number of votes as if such shares had been converted into
Ordinary Shares.
Board of Directors
Immediately following the Closing, the board of directors of the Company
(the "Board") shall consist of a maximum of five (5) members: for so long
the holders of Ordinary Shares hold together the majority of the Company
share capital, they may appoint three (3) directors and the holders of
Preferred Shares may appoint two directors ("Preferred Directors") and, as
of the time the holders of Ordinary Shares are no longer hold together the
majority of the Company share capital. they may appoint two (2) directors
EFTA00585325
and the holders of Preferred Directors will be consist of three (3) directors.
This provision will also apply to any subsidiary of the Company.
D&O Insurance
The Company will sign an indemnity agreement with each of the directors
and will maintain Directors & Officers liability insurance, reasonably
satisfactory to the Investor.
Signatory Rights
At or prior to the Initial Closing, the Company shall adopt a resolution
effecting the signatory rights which is satisfactory to the Investor.
Information and
Management rights
Until a QIPO, Investor shall have the right to receive: (i) a financial
statements within 60 days after the end of each fiscal year, which have been
audited by one of the "Big Four" accounting firms; (ii) an unaudited, but
reviewed, quarterly financial statement within 45 days after the end of the
first, second and third quarters of each fiscal year; (iii) a monthly report in a
form agreed by the Board including the Preferred Directors, within 15 days
after the end of each month, which report shall include a business update
and overview, profit and loss and cash-flow statement; (iv) an annual
operating plan and budget at least 30 days prior to the first day of the year
covered by such plan and (v) such other information as may be reasonably
required by Investor.
Investor shall also be entitled to standard inspection and visitation rights.
Pre-emptive Right
Until a QIPO, the Investor will have the right, but not an obligation, to
participate in any future sales of securities by the Company, upon the terms
of such round of financing, and to purchase in such round up to 100% of the
Company's securities offered in such sale.
The Preferred Holder may assign this right to their Permitted Transferees (as
shall be defined in the Company's Articles of Association).
Right of First Refusal
Until a QIPO, each shareholder of the Company holding at least 2% of the
issued and outstanding shares of the Company (calculated on an as
converted basis) ("Eligible Shareholder") shall have a pro-rata right of first
refusal with respect to any sale, transfer or disposition of share capital of the
Company by any other shareholder of the Company, other than a transfer to
Permitted Transferees ("Transfer").
Notwithstanding the foregoing any sale, transfer or disposition of share
capital of the Company by the Investor, shall not be subject to such right of
first refusal of the other shareholders.
Tag Along Right
Until a QIPO, the Investor shall have the right, with respect to any Transfer,
to sell, up to all of its shareholdings in the Company, prior and in preference
to any other shareholder in the Company; on the same general terms and
conditions proposed under such Transfer ("Preferred Tag Along Right").
Thereafter, any shares remaining under a Transfer following the exercising
of the Preferred Tag Along Right, if any, shall be subject to a pro rata right
of each Eligible Shareholder, to participate in such Transfer on the same
general terms and conditions proposed thereunder.
Registration Rights
Holders of a majority of the Registrable Shares (as defined below) shall
have the right, to one "demand" registration of their shares in the Company,
at the Company's expense. All Shareholders of the Company shall be
entitled to unlimited "piggyback" registration rights and one F-3 registration
per a calendar year, to be initiated by Holders of a majority of the
Registrable Shares (provided the aggregate offering price in such F-3
EFTA00585326
registration is at least US$ 1,000,000) at the Company's expense. In the
case of underwriter cut-backs, the shares of the Investor shall have priority
over all other shares in the Company to be included in any offering in a ratio
of 3:1 (1 ordinary share for every 3 Registrable Shares). All shareholders
agree to a I80-day lock-up after the IPO and 90 day lock up after
subsequent offerings of the Company. Registration rights will be freely
assignable in connection with any transfer of Registrable Shares. For the
purposes of this section, "Registrable Shares" shall mean the Preferred
Shares of the Company and any Ordinary Shares issued upon conversion of
the Preferred Shares. Any future registration rights granted by the Company
which are superior to those granted to the holders of Preferred Shares will be
subject to the approval of the majority of the holders of the Preferred Shares.
Restrictions on Sale:
Until the earlier of a QIPO, a Deemed Liquidation or the lapse of four (4)
years as of the Closing, the Founders shall not be entitled to sell any of their
shares in the Company, subject to standard exceptions for transfers to
Permitted Transferees.
Founders
Undertakings
Each Founder will enter into a non-competition and non-solicitation
agreement, and an employment agreement in a form reasonably acceptable
to the Investor, and shall agree to devote his entire business time and
attention to the Company and to not undertake additional activities without
the consent of the Investor. A breach of any of the foregoing restrictive
covenants or undertakings by a Founder shall result in immediate dismissal
for cause of such Founder.
Employee Vesting
100% of the shares of the Founders ("Restricted Shares") will be subject to
"reverse vesting" mechanism over a period of 3 years, with a one year cliff,
contingent - with regard to the shares of each Founder - on that Founder's
continued employment with the Company. Vesting shall be as follows: 1/3
of each Founder's Restricted Shares shall vest upon the first anniversary of
the Closing, and the remainder 213 of such Founder's Restricted Shares shall
vest on a quarterly basis over the remaining 2 years. Any unvested shares
will immediately vest upon an event of Change of Control and the
engagement of such Founder with the Company is terminated by the
Company not for cause.
Documentation and
Warranties
Detailed definitive agreements shall be drafted by counsel to the Investor
and shall include customary covenants, representations and warranties of the
Company and the Founders reflecting the provisions set forth herein and
other provisions typical to venture capital transactions ("Definitive
Agreements").
Expenses
The Company shall bear its own fees and expenses and shall pay at the
Closing all legal fees and expenses of the Investor, incurred with respect to
the transaction contemplated hereby.
Exclusivity
For a period of 60 business days following the execution of this letter,
neither the Company or the Founders nor any agent, directly or indirectly,
will solicit, consider, negotiate or otherwise discuss a possible merger, sale
or other disposition of all or any part of the shares or assets of the Company
or an investment in its share capital with any other party. Also, during said
60 business day period the Company will not issue any securities of the
Company nor will it permit a transfer of any securities of the Company.
Said period will automatically be extended by an additional 15 business
EFTA00585327
days if the parties are still negotiating the definitive agreements at the
conclusion of said 60 day period.
Confidentiality
The Company and Founders agree to treat this letter confidentially and will
not distribute or disclose its existence or contents outside the Company
without the consent of the Investor, except as required to its shareholders
and professional advisors.
Ordinary Course
Until the Closing, the Company will conduct its business solely in the ordinary
course of business and, among other things, will not declare or make any
distribution to shareholders, enter into any related party transaction or sell its
assets (other than the Company's products sold in the ordinary course of
business).
Non-binding Effect
This letter is not intended to be legally binding, and prepared for discussion
purposes only, as a statement of the Investor's present intent, with the
exception of this paragraph and the paragraphs entitled 'Exclusivity' and
'Confidentiality', which are binding upon the parties hereto and shall be
governed and construed in accordance with the laws of the State of Israel.
Acknowledged and agreed:
[INVESTOR
Mr. Amir Elichai
By:
Print Name:
Title:
Reporty Homeland Security Ltd.
By:
Print Name:
Title:
Alexander Dizengoff
Date-
Yoni Yitzon
Lital Leshaem
EFTA00585328
Technical Artifacts (2)
View in Artifacts BrowserEmail addresses, URLs, phone numbers, and other technical indicators extracted from this document.
Wire Ref
Transfer followingWire Ref
reflectingForum Discussions
This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.